SecBot SecBot
S-3 ·Filed Oct 23, 2026

BGMS

Bio Green Med Solution, Inc.
BEARISH
Impact 7/10
Horizonweeks Processed2d 18h ago SEC0001493152-26-048230
Shelf registration — potential dilution
Actionable Insight ▼ Bearish

Monitor for the S-3 effectiveness date — once effective, selling stockholders can immediately begin selling into the market. The 16.7% overhang on a $7M cap with limited liquidity creates acute downside risk. The November 19 special meeting vote on the Future NRG business combination is a binary catalyst that could render current equity nearly worthless (<1% ownership) if approved. Traders should watch for any prospectus supplement indicating the start of sales.

DirectionBearish
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

BGMS filed an S-3 shelf registration to register 1,103,338 shares for resale by selling stockholders who acquired them at $0.72/share in a June 2026 private placement. The company receives no proceeds; the filing fulfills registration rights obligations. The shares represent ~16.7% of outstanding stock and will become freely tradable once effective, creating significant overhang on a $7M market cap stock with limited liquidity.

Key Facts

  • S-3 registers 1,103,338 shares for resale by selling stockholders — 16.7% of 6,622,794 shares outstanding
  • Shares acquired at $0.72/share in a June 10, 2026 private placement; aggregate gross proceeds were $794,403
  • Company receives no proceeds from this resale registration
  • Selling stockholders include five parties, each holding ~3.33% pre-offering; all intend to sell 100%
  • Auditor's report includes a going-concern explanatory paragraph
  • Pending business combination with Future NRG valued at $2 billion would dilute current stockholders to <1% ownership
  • Special meeting on November 19, 2026 to vote on the business combination, authorized share increase to 3B, and reverse split
  • 9 offering/registration filings in the last 24 months; market cap is only $7M

Financial Impact

Potential selling pressure from up to 1,103,338 shares (~16.7% of outstanding) hitting a thinly traded $7M market cap stock; selling stockholders acquired at $0.72/share and may sell at any price above that

dilutionstock priceliquidity

Risk Factors

  • Immediate selling pressure from registered shares once S-3 is effective
  • Going-concern risk flagged by auditor
  • Proposed business combination would dilute current stockholders to <1% ownership
  • Multiple reverse splits in 2025 (1:16 and 1:15) indicate prior distress and Nasdaq compliance issues
  • Low liquidity amplifies impact of any selling

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
S-3 Filing (Primary)0001493152-26-048230
Exhibit: ex107.htm0001493152-26-048230
Exhibit: ex5-1.htm0001493152-26-048230
Exhibit: ex23-1.htm0001493152-26-048230
Document: 0001493152-26-048230-index-headers.html0001493152-26-048230
Document: 0001493152-26-048230-index.html0001493152-26-048230
Document: 0001493152-26-048230.txt0001493152-26-048230
7 reports for BGMS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for BGMS — sortable, filterable
TypeNow
Oct 23, 2026
2d ago
S-3
BEARISH ★ 7/10
$0.9050awaiting T+20—$0.9500 (−4.97%)
Oct 16, 2026
9d ago
8-K
NEUTRAL ★ 2/10
$0.9329awaiting T+20—$0.9500 (+1.83%)
Oct 9, 2026
17d ago
EFFECT
NEUTRAL ★ 4/10
$0.8490awaiting T+20—$0.9500 (+11.90%)
Aug 13, 2026
10w ago
8-K
BEARISH ★ 8/10
$0.9150 $0.8976▲ +1.90%▼ −0.09%$0.9500 (−3.83%)
Jul 24, 2026
13w ago
S-4/A
BEARISH ★ 8/10
$0.9249 $0.8705▲ +5.88%▲ +9.18%$0.9500 (−2.71%)
Jun 4, 2026
20w ago
Press Release
NEUTRAL ★ 5/10
$1.50 $0.9398▼ −37.35%▼ −39.21%$0.9500 (−36.67%)
Mar 30, 2026
29w ago
Press Release
MIXED ★ 5/10
$1.00 $0.9600▼ −4.00%▼ −13.42%$0.9500 (−5.00%)
Showing 7 of 7

US Market Status

Market Open — Closes in 5h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 23, 2026